What’s really driving the cost of health care in 2023?

On January 10, as part of PhRMA’s sponsorship of Fierce Pharma’s J.P. Morgan Health Care Conference event, PhRMA’s COO Lori Reilly joined Fierce Pharma’s Rebecca Willumson for a fireside chat on the initial intent of the 340B program, how the program has shifted away from its original purpose and ways to fix the 340B program so that it works for patients.


January 10, 2023 at 9:35 AM PT


  • Lori M. Reilly, Esq., Chief Operating Officer, PhRMA
  • Rebecca Willumson, Senior Vice President & Publisher, Fierce Biotech, Fierce Pharma & Fierce Healthcare


This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.